Skip to main content
. 2022 Sep 21;315(3):521–530. doi: 10.1007/s00403-022-02398-0

Table 1.

Comparison between both groups at baseline

Azithromycin group (n = 13)
(mean ± SD)
NB-UVB (n = 11)
(mean ± SD)
p value
Age (years) 12 ± 5.29 18.73 ± 19.02 0.279
Sex

Females 8 (72.7%)

Males 5 (38.5%)

Females 3 (27.3%)

Males 8 (61.5%)

0.102
Duration (months) 27.46 ± 22.99 25.18 ± 19.49 0.795
Extent of the rash as a whole (% body surface) 18.56 ± 13.94 12.27 ± 5.27 0.152
Extent of the erythematous papules (% body surface)
 Face 0.31 ± 0.59 0.16 ± 0.32 0.443
 Trunk (front) 2.13 ± 2.41 1.23 ± 1.21 0.248
 Trunk (back) 1.85 ± 2.47 1.27 ± 1.12 0.463
 Upper extremities 3.13 ± 4.80 1.93 ± 1.78 0.352
 Lower extremities 3.75 ± 4.33 2.05 ± 1.27 0.198
 Total extension 11.9 ± 13.54 6.68 ± 3.96 0.271
Extent of the hypopigmented lesions (% body surface)
 Face 0.35 ± 0.42 0.27 ± 0.39 0.662
 Trunk (front) 1.63 ± 2.67 1.18 ± 1.03 0.581
 Trunk (back) 1.48 ± 2.62 1.05 ± 1.01 0.589
 Upper extremities 1.75 ± 2.05 1 ± 0.74 0.238
 Lower extremities 2 ± 2.04 2.09 ± 1.87 0.91
 Total extension 7.37 ± 9.33 5.59 ± 3.91 0.541

*p value < 0.05 is significant